Viewing StudyNCT02339532



Ignite Creation Date: 2024-05-06 @ 3:37 AM
Last Modification Date: 2024-10-26 @ 11:36 AM
Study NCT ID: NCT02339532
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-12-07
First Post: 2014-12-14

Brief Title: Neoadjuvant Phase II Trial in Patients With T1c Operable HER2-positive Breast Cancer According to TOP2A Status
Sponsor: UNICANCER
Organization: UNICANCER

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
TOP2A View
HER2-positive View
non-metastatic View